OBJECTIVES: To prepare for future HIV prevention trials, we conducted prospective cohort studies among women working in food and recreational facilities in northern Tanzania. We examined the prevalence and incidence of HIV and HSV-2, and associated risk factors. METHODS: Women aged 18-44 years working in food and recreational facilities were screened to determine their eligibility for the studies. Between 2008-2010, HIV-negative women were enrolled and followed for 12 months. At enrolment and 3-monthly, we collected socio-demographic and behavioural data, and performed clinical examinations for collection of biological specimens that were tested for reproductive tract infections. Risk factors for HIV and HSV-2 incidence were investigated us...
OBJECTIVES: Information on pregnancy rates and factors associated with pregnancy and contraceptive u...
BackgroundThe study aimed to assess the feasibility of conducting large scale HIV prevention clinica...
Background: Testing and evaluating new HIV prevention products such as HIV vaccines, requires ident...
To prepare for future HIV prevention trials, we conducted prospective cohort studies among women wor...
<div><p>Objectives</p><p>To prepare for future HIV prevention trials, we conducted prospective cohor...
To prepare for future HIV prevention trials, we conducted prospective cohort studies among women wor...
OBJECTIVES: To determine prevalence of and risk factors for herpes simplex virus type 2 (HSV-2) and ...
BACKGROUND: A feasibility study was conducted to investigate whether an occupational at-risk cohort ...
OBJECTIVES: To determine baseline characteristics of an occupational cohort of women in Mwanza City,...
OBJECTIVES: A randomized, double-blind, placebo-controlled trial (RCT) of herpes simplex virus type ...
BACKGROUND: Infection with herpes simplex virus type 2 (HSV-2) is associated with an increased risk ...
BACKGROUND: Young people are at high risk of HIV and developing appropriate prevention programmes re...
BACKGROUND: The study aimed to assess the feasibility of conducting large scale HIV prevention clini...
Background: Evidence suggests that a substantial proportion of new HIV infections in African countri...
OBJECTIVE: To describe the evolution of the HIV-1 epidemic among women attending antenatal clinics i...
OBJECTIVES: Information on pregnancy rates and factors associated with pregnancy and contraceptive u...
BackgroundThe study aimed to assess the feasibility of conducting large scale HIV prevention clinica...
Background: Testing and evaluating new HIV prevention products such as HIV vaccines, requires ident...
To prepare for future HIV prevention trials, we conducted prospective cohort studies among women wor...
<div><p>Objectives</p><p>To prepare for future HIV prevention trials, we conducted prospective cohor...
To prepare for future HIV prevention trials, we conducted prospective cohort studies among women wor...
OBJECTIVES: To determine prevalence of and risk factors for herpes simplex virus type 2 (HSV-2) and ...
BACKGROUND: A feasibility study was conducted to investigate whether an occupational at-risk cohort ...
OBJECTIVES: To determine baseline characteristics of an occupational cohort of women in Mwanza City,...
OBJECTIVES: A randomized, double-blind, placebo-controlled trial (RCT) of herpes simplex virus type ...
BACKGROUND: Infection with herpes simplex virus type 2 (HSV-2) is associated with an increased risk ...
BACKGROUND: Young people are at high risk of HIV and developing appropriate prevention programmes re...
BACKGROUND: The study aimed to assess the feasibility of conducting large scale HIV prevention clini...
Background: Evidence suggests that a substantial proportion of new HIV infections in African countri...
OBJECTIVE: To describe the evolution of the HIV-1 epidemic among women attending antenatal clinics i...
OBJECTIVES: Information on pregnancy rates and factors associated with pregnancy and contraceptive u...
BackgroundThe study aimed to assess the feasibility of conducting large scale HIV prevention clinica...
Background: Testing and evaluating new HIV prevention products such as HIV vaccines, requires ident...